London, February 4, 2020 – Hikma Pharmaceuticals PLC (Hikma, Group / LSE: HIK / NASDAQ Dubai: HIK / OTC: HKMPY) (rated Ba1/stable Moody’s and BB+/positive S&P), will announce its preliminary financial results for the year ended 31 December 2019 on Thursday 27 February 2020.
4 February 2020
Corporate, Press Release
A presentation and webcast for analysts will be held on 27 February 2020 at 9:30am GMT, for further information about the meeting, please get in contact with Tiina Lugmayer – Tiina@Hikma.uk.com.
To join via conference call please dial:
United Kingdom 0800 640 6441
United Kingdom (local) 020 3936 2999
All other locations +44 20 3936 2999
Access code: 442936
The results presentation and a webcast recording of the event will be available on the Company's website at www.hikma.com or https://webcast.openbriefing.com/hikma-prelim2019/.
Playback facility:
A playback of the conference call will be available up to six months after the presentation.
UK: 020 3936 3001
USA: 1 845 709 8569
All other locations: +44 20 3936 3001
Access code: 169303